Online citations, reference lists, and bibliographies.
← Back to Search
DOI: 10.1016/0002-9378(71)90799-X

Antithrombin III Depression And Thrombin Generation Acceleration In Women Taking Oral Contraceptives

E. V. Kaulla, W. Droegemueller, N. Aoki, K. Kaulla
Published 1971 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Abstract The blood clotting systems of 21 women were studied prior to and modified by steroid contraceptives. The oral contraceptives induced a depression of antithrombin III activity and an acceleration of thrombin generation within the first cycle of therapy. These changes are similar to those observed in patients with chronic thromboembolic disease. It is suggested that of all the clotting changes induced by the oral contraceptives the loss of antithrombin III activity may be the one that is the most clinically significant.
This paper references
10.1055/S-0028-1111129
[Influence of ovulation inhibitors on clinicochemical norms].
L. Wilbert (1969)
10.1136/BMJ.1.5646.780
Jaundice and methyldopa.
R. Wyburn-Mason (1969)
10.1126/science.166.3904.517
Antithrombin III: Protection against Death after Injection of Thromboplastin
L. Mann (1969)
10.1161/01.RES.14.5.436
Thrombin Generation in Normal Subjects and Cardiac Patients
K. Kaulla (1964)
10.1093/AJCP/29.2.104
Methods for the evaluation of human fibrinolysis; studies with two combined technics.
K. V. von Kaulla (1958)
10.1515/9783110881707
Thrombose und Embolie
A. Ritter (1955)
10.1016/S0002-9378(33)80008-1
The influence of female sex hormone upon blood coagulation of the newborn
J. C. Hirst (1933)
10.1093/AJCP/48.1.69
Antithrombin III and Diseases
E. Kaulla (1967)



This paper is referenced by
10.1161/01.RES.35.1.1
Brief Reviews: Some Recent Advances in the Study of Hemostasis
O. Ratnoff (1974)
10.1016/S1051-0443(04)70119-0
Limitations of Medical/Surgical Management of DVT
N. Patel (2004)
10.1016/0049-3848(79)90173-7
Effect of oral contraceptive use on platelet prothrombin converting (platelet factor 3) activity.
B. Leff (1979)
10.1016/S0002-9378(16)32582-0
Menopausal status associated with increased inhibition of blood coagulation.
M. Notelovitz (1981)
10.1146/ANNUREV.ME.31.020180.001553
Effectiveness and risks of contraception.
W. Droegemueller (1980)
10.1111/j.1471-0528.1982.tb05081.x
Oral contraceptives and venous thromboembolism
A. Bergqvist (1982)
10.1007/978-1-4471-1446-8_1
Preoperative Preparation of the Patient
Jean-Pierre van Besouw (1987)
10.1007/978-1-4613-2241-2_2
Oral Contraceptives and the Occurrence of Disease
B. V. Stadel (1986)
10.1007/BF01470929
Beeinflussung von Blutgerinnung und Fibrinolyse durch Oestrogen, Gestagen und eine Oestrogen-Gestagen-Kombination
K. Lechner (2005)
10.1016/0378-5122(88)90012-6
Risks and benefits of oral contraceptive use in women over 35.
D. Cramer (1988)
Effects of a new antiovulatorvsteroiid~ otroiins, prolactin &d coagulation
P. F. Tauberl (1975)
10.1016/S0140-6736(75)91350-1
NATURAL ŒSTROGENS AND ANTITHROMBIN-III LEVELS
H. B. Greig (1975)
10.3109/00016347609156445
ESTROGENS AND THROMBOEMBOLIC DISEASES
G. Zador (1976)
10.2491/JJSTH1970.10.292
Effect of estrogen platelet aggregation induced by thrombin
H. Nagasawa (1979)
10.1016/0028-2243(75)90160-4
Effects of a new antiovulatory steroid on gonadotropins, prolactin and blood coagulation.
P. Tauber (1975)
10.1016/0002-9378(74)90680-2
The effect on blood coagulation of ovariectomy and hysterectomy in rats given ethinyl estradiol.
R. Mackenzie (1974)
10.1016/S0889-8588(05)70349-X
Hypercoagulability in cancer.
K. B. Green (1996)
10.1007/978-3-642-67843-1_5
Thromboseneignung durch Änderungen der plasmatischen Gerinnung
H. Vinazzer (1981)
10.1111/j.1423-0410.1979.tb04436.x
Development of Large Scale Fractionation Methods
M. Wickerhauser (1972)
10.1016/S0140-6736(73)90633-8
Oral contraceptives and the N.B.T. test.
B. Björkstén (1973)
10.1016/S0140-6736(73)91794-7
ANTITHROMBIN III AND ŒSTROGEN CONTENT OF ORAL CONTRACEPTIVES
P. Howie (1973)
10.1016/b978-1-4160-5223-4.00048-2
Acute Deep Venous Thrombosis
F. Vandy (2010)
10.1007/BF02601259
Zur Problematik der akuten spontanen Thrombose der Arteria poplitea
P. Polterauer (2007)
10.1002/ART.1780291221
Systemic lupus erythematosus, antiphospholipid antibodies, chorea, and oral contraceptives.
R. Asherson (1986)
10.1111/J.1365-2273.1990.TB00792.X
Oral contraceptive therapy and the surgical management of ENT patients: a review of current clinical practice.
R. Williams (1990)
10.1016/S0140-6736(73)91793-5
Assessment of tennis-elbow.
A. J. Richards (1973)
10.1016/0049-3848(74)90175-3
Contact activation of heparinized plasma.
J. Caprini (1974)
10.1016/0378-5122(94)90127-9
Early effects of continuous low-dosage all-norgestrel administered alone or with estrogen.
B. Wolfe (1994)
10.1016/B978-0-12-783402-3.50018-4
Chapter 11 – THROMBOSIS
N. Rodman (1973)
10.1007/BF03350007
Endocrine therapy of metastatic breast cancer
A. Manni (1989)
10.1016/B978-2-294-70921-0.00006-1
6 – Contraception hormonale
D. Serfaty (2011)
10.1016/B978-0-7506-1032-2.50021-5
Acute and subacute deep vein thrombosis in the lower limb
D. Tibbs (1992)
See more
Semantic Scholar Logo Some data provided by SemanticScholar